Phenotypic and Genotypic Associations With Symptom Clusters During Childhood Leukemia Treatment
A repeated measures research design will evaluate phenotypic and genotypic treatment-related
symptom associations experienced by children and adolescents 3-17 years of age with a
diagnosis of leukemia.
- Phenotypic and genotypic treatment-related symptom associations will be evaluated in
children and adolescents 3-18 years of age with a diagnosis of leukemia.
- Children without a definite diagnosis of leukemia will be excluded.
- Children must be able to understand and answer the questions on the questionnaires.
- Children with have a cognitive impairment (e.g. Down syndrome) will not be able to
complete the questionnaires and will not be eligible for the study.
Type of Study:
Observational Model: Cohort, Time Perspective: Prospective
Marilyn Hockenberyy, PhD
Duke University School of Nursing
United States: Institutional Review Board
- Childhood Leukemia
|Duke University Medical Center||Durham, North Carolina 27710|